Galaxy Medicare
- Market cap
- ₹ 27 Cr.
- P/E
- 7.8x
- P/B
- 0.71x
- 52-week range
- 15.15 – 23.8
- ROE
- 11%
- ROCE
- 13.9%
- Dividend yield
- 3.7%
- Debt / equity
- 0.1
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- NSE SME
About
Galaxy Medicare Limited is an India-based company engaged in the manufacturing, trading and exporting of medical devices, plasters of paris (POP) bandages and other surgical dressings in India. The Company is engaged in the manufacturing and branding of its own products under its flagship brands POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, and FIXCAN, among others. With a portfolio of 27 registered trademarks in India under various brand names, it offers a diverse range of POP bandages, medical tapes and bandages, other surgical dressings and external preparation products for wound care and wound management, including sterile surgical wound dressing, medical disposables, adhesive bandages, absorbent gauze, among others. Its products are supplied all over India to central and state government health departments, corporate and private hospitals, among others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →Galaxy Medicare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)7.8 against a typical 28.7: cheaper than most peers (1st = cheapest).2nd of 25
- Share price, 3 months+6.5% against a typical −7.9%.5th of 23
- Size₹ 27.4 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).22nd of 24
Latest announcements
Exchange filings and their impact on the company.
- Post-IPO presentation shows core bandage lines full and IPO cash funding debottlenecking for mid-teens growth.
Galaxy Medicare shared an October 2026 investor presentation covering its medical devices and surgical dressings business. It reported FY26 revenue of Rs 40 crore with 10.75% EBITDA margin, exports of Rs 9.8 crore, and full utilisation on POP bandage at 106% and elastic bandage at 91%. The company said IPO funds will be used for new machinery including a pre-cotton cleaning line, own-brand growth, more OEM work, government tenders and exports.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 29 May 2026 | Financial Results/Dividend | To Consider and Approve the Financial Results for the Period Ended March 31, 2026 and Dividend |
| 10 Dec 2025 | Financial Results/Dividend | GML : 10-Dec-2025 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on December 10, 2025, To consider and approve the financial results for the period ended September 30, 2025 and dividend |
| 13 Nov 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 17 | 22 | 19 | 21 |
| Expenses | 15 | 20 | 16 | 20 |
| Operating Profit | 3 | 2 | 3 | 1 |
| OPM % | 14.5% | 9.8% | 15.3% | 6.4% |
| Other Income | 1 | 1 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 2 | 3 | 2 |
| Tax % | 29.3% | 21.8% | 27.3% | 27.3% |
| Net Profit | 2 | 2 | 2 | 1 |
| EPS in Rs | 1.44 | 1.4 | 1.33 | 0.92 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 7%
- 3 Years
- 9%
- TTM
- 2%
- 10 Years
- —
- 5 Years
- 36%
- 3 Years
- 59%
- TTM
- 8%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 14%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Galaxy Medicare | ₹ 18.00 | ₹ 27 Cr. | 7.8x | 0.7x | 11% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 217x | 12.9x | — | 6.9% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 49.6x | 5.2x | — | 15.7% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 29.6x | 4.2x | — | 10% |
| Hemant Surgical Industries | ₹ 570.00 | ₹ 829 Cr. | 41.3x | 5.6x | 18.1% | 7.9% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 17.9x | 1.8x | — | 5.1% |
Management
- Dillip Kumar Das
- Executive Chairman of the Board, Managing Director
- Tapas Kumar Dhal
- Chief Financial Officer
- Pralaaju Naik
- Company Secretary, Compliance Officer
- Kiran Das
- Whole Time Director
- Subhasis Hdas
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.